ACTAVIA LIFE SCIENCES, INC.: 10-Q filed 2019-05-15
What ACTAVIA LIFE SCIENCES, INC. reported in its quarterly report filed 2019-05-15 (fiscal Q2 2019): 25 published measures, 62 facts as tagged in accession 0001213900-19-008887.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2019-05-15
- Fiscal period
- fiscal Q2 2019
- Accession
- 0001213900-19-008887 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All ACTAVIA LIFE SCIENCES, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 5,037,932 | USD | |
| At 2018-09-30 | 5,225,269 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 2,378,253 | USD | |
| At 2018-09-30 | 2,119,613 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 2,659,679 | USD | |
| At 2018-09-30 | 3,105,656 | USD | |
| At 2018-03-31 | 4,160,696 | USD | |
| At 2017-09-30 | 6,037,736 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 42,413 | USD | |
| At 2018-09-30 | 42,693 | USD | |
| At 2018-03-31 | 539,393 | USD | |
| At 2017-09-30 | 2,537,611 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -265,360 | USD | 90 |
| 2018-10-01 to 2019-03-31 | -666,664 | USD | 182 |
| 2018-01-01 to 2018-03-31 | -1,144,412 | USD | 90 |
| 2017-10-01 to 2018-03-31 | -2,867,013 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-03-31 | -100,280 | USD | 182 |
| 2017-10-01 to 2018-03-31 | -1,994,145 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | 4,073 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-03-31 | 100,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2017-10-01 to 2018-03-31 | -4,073 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | -17,042,093 | USD | |
| At 2018-09-30 | -16,375,429 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 2,767 | USD | |
| At 2018-09-30 | 5,420 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-03-31 | 220,687 | USD | 182 |
| 2017-10-01 to 2018-03-31 | 467,623 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -263,290 | USD | 90 |
| 2018-10-01 to 2019-03-31 | -662,618 | USD | 182 |
| 2018-01-01 to 2018-03-31 | -1,136,717 | USD | 90 |
| 2017-10-01 to 2018-03-31 | -2,855,642 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 162,811 | USD | |
| At 2018-09-30 | 347,495 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 2,378,253 | USD | |
| At 2018-09-30 | 2,108,995 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 829,903 | USD | |
| At 2018-09-30 | 719,830 | USD |
Goodwill carrying amount
Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 2,722,985 | USD | |
| At 2018-09-30 | 2,722,985 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | 263,290 | USD | 90 |
| 2018-10-01 to 2019-03-31 | 662,618 | USD | 182 |
| 2018-01-01 to 2018-03-31 | 1,136,717 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 2,855,642 | USD | 182 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-03-31 | 75,000 | USD | 182 |
| 2018-01-01 to 2018-03-31 | 32,582 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 209,514 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 68,908,003 | shares | |
| At 2018-09-30 | 68,908,003 | shares |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 752,865 | USD | |
| At 2018-09-30 | 701,825 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2019-03-31 | 43,498 | USD | |
| At 2018-09-30 | 66,936 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | 198,942 | USD | 90 |
| 2018-10-01 to 2019-03-31 | 383,507 | USD | 182 |
| 2018-01-01 to 2018-03-31 | 824,950 | USD | 90 |
| 2017-10-01 to 2018-03-31 | 1,698,751 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2018-10-01 to 2019-03-31 | 2,654 | USD | 182 |
| 2017-10-01 to 2018-03-31 | 3,117 | USD | 182 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2019-01-01 to 2019-03-31 | -2,070 | USD | 90 |
| 2018-10-01 to 2019-03-31 | -4,046 | USD | 182 |
| 2018-01-01 to 2018-03-31 | -7,695 | USD | 90 |
| 2017-10-01 to 2018-03-31 | -11,371 | USD | 182 |
Inspect the source
- Entity
- ACTAVIA LIFE SCIENCES, INC. / CIK 0001582249
- Captured
- SEC response SHA-256
1fa3da8551fa6523f67ea25c9d27ef0c331ae8c1fcbc6eda23b86adc30a6f71c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001582249.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))